Acrux Limited Logo

Acrux Limited

ACR.AX

(1.5)
Stock Price

0,04 AUD

-58.27% ROA

-130.13% ROE

-2.65x PER

Market Cap.

15.408.001,00 AUD

54.33% DER

0% Yield

-113.93% NPM

Acrux Limited Stock Analysis

Acrux Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Acrux Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (23%), which means it has a small amount of debt compared to the ownership it holds

2 PBV

The stock's PBV ratio (1.31x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

4 Net Profit Growth

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

5 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

6 ROE

Negative ROE (-71.36%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

7 ROA

The stock's ROA (-70.61%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Acrux Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Acrux Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Acrux Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Acrux Limited Revenue
Year Revenue Growth
2002 547.445
2003 746.307 26.65%
2004 3.264.806 77.14%
2005 2.711.090 -20.42%
2006 517.000 -424.39%
2007 2.897.000 82.15%
2008 3.841.000 24.58%
2009 650.000 -490.92%
2010 54.904.000 98.82%
2011 89.603.000 38.73%
2012 8.797.000 -918.56%
2013 15.549.000 43.42%
2014 53.859.000 71.13%
2015 25.368.000 -112.31%
2016 28.557.000 11.17%
2017 23.934.000 -19.32%
2018 3.432.000 -597.38%
2019 631.000 -443.9%
2020 1.253.000 49.64%
2020 1.253.000 0%
2021 1.337.000 6.28%
2022 1.719.000 22.22%
2023 8.429.000 79.61%
2024 2.728.000 -208.98%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Acrux Limited Research and Development Expenses
Year Research and Development Expenses Growth
2002 3.240.579
2003 4.417.967 26.65%
2004 3.109.926 -42.06%
2005 4.243.578 26.71%
2006 4.757.000 10.79%
2007 5.898.000 19.35%
2008 3.743.000 -57.57%
2009 1.581.000 -136.75%
2010 1.019.000 -55.15%
2011 1.025.000 0.59%
2012 905.000 -13.26%
2013 752.000 -20.35%
2014 2.033.999 63.03%
2015 5.058.000 59.79%
2016 6.868.000 26.35%
2017 21.312.000 67.77%
2018 16.614.999 -28.27%
2019 11.024.000 -50.72%
2020 5.012.000 -119.95%
2020 5.012.000 0%
2021 8.928.000 43.86%
2022 6.371.000 -40.13%
2023 3.812.000 -67.13%
2024 5.084.000 25.02%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Acrux Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 1.080.507
2003 2.054.436 47.41%
2004 3.025.098 32.09%
2005 3.982.535 24.04%
2006 4.960.000 19.71%
2007 4.721.000 -5.06%
2008 5.026.000 6.07%
2009 4.578.000 -9.79%
2010 2.889.000 -58.46%
2011 3.246.000 11%
2012 3.217.000 -0.9%
2013 2.950.000 -9.05%
2014 900.000 -227.78%
2015 1.147.000 21.53%
2016 916.000 -25.22%
2017 2.209.000 58.53%
2018 3.031.000 27.12%
2019 1.095.000 -176.8%
2020 5.938.000 81.56%
2020 696.000 -753.16%
2021 828.000 15.94%
2022 639.000 -29.58%
2023 532.000 -20.11%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Acrux Limited EBITDA
Year EBITDA Growth
2002 -3.773.641
2003 -5.706.102 33.87%
2004 -3.950.219 -44.45%
2005 -5.623.350 29.75%
2006 -11.783.000 52.28%
2007 -9.326.000 -26.35%
2008 -7.070.000 -31.91%
2009 -9.975.000 29.12%
2010 49.887.000 120%
2011 83.558.000 40.3%
2012 3.618.000 -2209.51%
2013 10.886.000 66.76%
2014 45.231.000 75.93%
2015 16.952.000 -166.82%
2016 19.024.000 10.89%
2017 11.218.000 -69.58%
2018 -9.328.000 220.26%
2019 -12.671.000 26.38%
2020 -8.677.000 -46.03%
2020 -11.369.000 23.68%
2021 -15.586.000 27.06%
2022 -12.306.000 -26.65%
2023 -2.795.000 -340.29%
2024 -16.376.000 82.93%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Acrux Limited Gross Profit
Year Gross Profit Growth
2002 547.445
2003 746.307 26.65%
2004 3.264.806 77.14%
2005 2.711.090 -20.42%
2006 517.000 -424.39%
2007 2.897.000 82.15%
2008 3.841.000 24.58%
2009 650.000 -490.92%
2010 52.991.000 98.77%
2011 86.595.000 38.81%
2012 8.536.000 -914.47%
2013 15.016.000 43.15%
2014 51.276.000 70.72%
2015 23.804.000 -115.41%
2016 26.139.000 8.93%
2017 20.559.000 -27.14%
2018 84.000 -24375%
2019 -4.492.000 101.87%
2020 1.253.000 458.5%
2020 -3.759.000 133.33%
2021 -7.591.000 50.48%
2022 -4.652.000 -63.18%
2023 1.946.000 339.05%
2024 -8.856.000 121.97%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Acrux Limited Net Profit
Year Net Profit Growth
2002 -3.144.783
2003 -10.015 -31300.73%
2004 -2.989 -235.06%
2005 23.965 112.47%
2006 -9.940.000 100.24%
2007 -7.860.000 -26.46%
2008 -5.026.000 -56.39%
2009 -7.716.000 34.86%
2010 46.554.000 116.57%
2011 57.148.000 18.54%
2012 7.391.000 -673.21%
2013 6.926.000 -6.71%
2014 27.970.000 75.24%
2015 11.130.000 -151.3%
2016 12.981.000 14.26%
2017 -243.000 5441.98%
2018 -14.182.000 98.29%
2019 -8.324.999 -70.35%
2020 -9.471.000 12.1%
2020 -9.471.000 0%
2021 -12.629.000 25.01%
2022 -9.834.000 -28.42%
2023 -764.000 -1187.17%
2024 -10.244.000 92.54%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Acrux Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Acrux Limited Free Cashflow
Year Free Cashflow Growth
2002 -3.094.138
2003 -1.335.763 -131.64%
2004 -4.443.321 69.94%
2005 -6.396.339 30.53%
2006 -8.786.000 27.2%
2007 -7.985.000 -10.03%
2008 -7.183.000 -11.17%
2009 -19.706.000 63.55%
2010 41.546.000 147.43%
2011 61.797.000 32.77%
2012 -2.515.000 2557.14%
2013 6.305.000 139.89%
2014 36.332.000 82.65%
2015 10.453.000 -247.57%
2016 16.270.000 35.75%
2017 4.747.000 -242.74%
2018 -5.578.000 185.1%
2019 -10.318.000 45.94%
2020 -8.791.000 -17.37%
2021 -11.516.000 23.66%
2022 -9.284.000 -24.04%
2023 584.000 1689.73%
2024 -3.006.000 119.43%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Acrux Limited Operating Cashflow
Year Operating Cashflow Growth
2002 -2.744.533
2003 0 0%
2004 -3.965.575 100%
2005 -5.902.160 32.81%
2006 -8.226.000 28.25%
2007 -7.698.000 -6.86%
2008 -2.713.000 -183.74%
2009 -5.781.000 53.07%
2010 48.119.000 112.01%
2011 65.104.000 26.09%
2012 -2.432.000 2776.97%
2013 6.335.000 138.39%
2014 36.371.000 82.58%
2015 10.519.000 -245.76%
2016 16.506.000 36.27%
2017 5.376.000 -207.03%
2018 -5.282.000 201.78%
2019 -9.938.000 46.85%
2020 -8.533.000 -16.47%
2021 -11.414.000 25.24%
2022 -8.819.000 -29.43%
2023 703.000 1354.48%
2024 -2.886.000 124.36%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Acrux Limited Capital Expenditure
Year Capital Expenditure Growth
2002 349.605
2003 1.335.763 73.83%
2004 477.746 -179.6%
2005 494.179 3.33%
2006 560.000 11.75%
2007 287.000 -95.12%
2008 4.470.000 93.58%
2009 13.925.000 67.9%
2010 6.573.000 -111.85%
2011 3.307.000 -98.76%
2012 83.000 -3884.34%
2013 30.000 -176.67%
2014 39.000 23.08%
2015 66.000 40.91%
2016 236.000 72.03%
2017 629.000 62.48%
2018 296.000 -112.5%
2019 380.000 22.11%
2020 258.000 -47.29%
2021 102.000 -152.94%
2022 465.000 78.06%
2023 119.000 -290.76%
2024 120.000 0.83%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Acrux Limited Equity
Year Equity Growth
2002 17.485.116
2003 11.664.921 -49.89%
2004 8.408.905 -38.72%
2005 29.481.791 71.48%
2006 20.583.000 -43.23%
2007 18.246.000 -12.81%
2008 38.109.000 52.12%
2009 31.223.000 -22.05%
2010 80.469.000 61.2%
2011 45.712.000 -76.03%
2012 53.103.000 13.92%
2013 46.753.000 -13.58%
2014 42.057.000 -11.17%
2015 40.625.000 -3.52%
2016 43.889.000 7.44%
2017 43.925.000 0.08%
2018 29.971.000 -46.56%
2019 21.936.000 -36.63%
2020 12.849.000 -70.72%
2021 18.471.000 30.44%
2022 9.090.000 -103.2%
2023 8.696.000 -4.53%
2024 3.276.000 -165.45%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Acrux Limited Assets
Year Assets Growth
2002 18.355.576
2003 12.846.083 -42.89%
2004 9.757.512 -31.65%
2005 31.093.624 68.62%
2006 23.234.000 -33.83%
2007 20.369.000 -14.07%
2008 41.267.000 50.64%
2009 34.950.000 -18.07%
2010 83.605.000 58.2%
2011 58.995.000 -41.72%
2012 58.499.000 -0.85%
2013 52.895.000 -10.59%
2014 53.221.000 0.61%
2015 48.495.000 -9.75%
2016 53.371.000 9.14%
2017 47.306.000 -12.82%
2018 32.490.000 -45.6%
2019 24.433.000 -32.98%
2020 18.521.000 -31.92%
2021 24.202.000 23.47%
2022 15.273.000 -58.46%
2023 14.299.000 -6.81%
2024 9.954.000 -43.65%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Acrux Limited Liabilities
Year Liabilities Growth
2002 870.460
2003 1.181.162 26.3%
2004 1.348.607 12.42%
2005 1.611.833 16.33%
2006 2.651.000 39.2%
2007 2.123.000 -24.87%
2008 3.158.000 32.77%
2009 3.727.000 15.27%
2010 3.136.000 -18.85%
2011 13.283.000 76.39%
2012 5.396.000 -146.16%
2013 6.142.000 12.15%
2014 11.164.000 44.98%
2015 7.870.000 -41.86%
2016 9.482.000 17%
2017 3.381.000 -180.45%
2018 2.519.000 -34.22%
2019 2.497.000 -0.88%
2020 5.672.000 55.98%
2021 5.731.000 1.03%
2022 6.183.000 7.31%
2023 5.603.000 -10.35%
2024 6.678.000 16.1%

Acrux Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.02
Net Income per Share
-0.02
Price to Earning Ratio
-2.65x
Price To Sales Ratio
3.03x
POCF Ratio
-3.57
PFCF Ratio
-3.36
Price to Book Ratio
4.69
EV to Sales
3.18
EV Over EBITDA
-2
EV to Operating CashFlow
-3.76
EV to FreeCashFlow
-3.53
Earnings Yield
-0.38
FreeCashFlow Yield
-0.3
Market Cap
0,02 Bil.
Enterprise Value
0,02 Bil.
Graham Number
0.07
Graham NetNet
-0.01

Income Statement Metrics

Net Income per Share
-0.02
Income Quality
0.74
ROE
-1.3
Return On Assets
-0.58
Return On Capital Employed
-1.38
Net Income per EBT
0.69
EBT Per Ebit
0.98
Ebit per Revenue
-1.68
Effective Tax Rate
0.31

Margins

Sales, General, & Administrative to Revenue
0.04
Research & Developement to Revenue
0.47
Stock Based Compensation to Revenue
0.04
Gross Profit Margin
-0.88
Operating Profit Margin
-1.68
Pretax Profit Margin
-1.66
Net Profit Margin
-1.14

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.02
Capex to Operating CashFlow
-0.06
Capex to Revenue
0.05
Capex to Depreciation
0.54
Return on Invested Capital
-1.17
Return on Tangible Assets
-0.58
Days Sales Outstanding
207.13
Days Payables Outstanding
40.92
Days of Inventory on Hand
0
Receivables Turnover
1.76
Payables Turnover
8.92
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
0,01
Tangible Book Value per Share
0.01
Shareholders Equity per Share
0.01
Interest Debt per Share
0.01
Debt to Equity
0.54
Debt to Assets
0.18
Net Debt to EBITDA
-0.09
Current Ratio
1.61
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
4669000
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.12

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Acrux Limited Dividends
Year Dividends Growth
2011 1
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%

Acrux Limited Profile

About Acrux Limited

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.

CEO
Mr. Michael John Kotsanis B.Sc
Employee
43
Address
103-113, Stanley Street
West Melbourne, 3003

Acrux Limited Executives & BODs

Acrux Limited Executives & BODs
# Name Age
1 Ms. Joanna Johnson B.E., BEc, ICAA
Chief Financial Officer & Company Secretary
70
2 Mr. Michael John Kotsanis B.Sc., BSc, GradDipBus, MBus
Chief Executive Officer, MD & Executive Director
70

Acrux Limited Competitors